Jun 22, 2022 7:05am EDT IMV Strengthens Its Financial Position With the $US10 Million Drawdown From Its Existing Long-Term Debt Facility
May 06, 2022 7:05am EDT IMV Inc. to Announce First Quarter 2022 Results and Host a Conference Call and Webcast on May 13, 2022
Apr 28, 2022 7:05am EDT IMV’s Lead Compound to Be Showcased in Two Presentations at the 2022 ASCO Annual Meeting
Apr 08, 2022 5:00pm EDT IMV Inc. Presents Clinical Benefit of MVP-S in Combination with Pembrolizumab in Bladder Cancer at the AACR Annual Meeting
Mar 17, 2022 7:05am EDT IMV Inc. Announces Fourth Quarter and Full Year 2021 Financial and Operational Results
